http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012146816-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-323 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2011-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012146816-A |
| titleOfInvention | TREATMENT OF DISEASES ASSOCIATED WITH AN APOPTIC RESPONSE PROTEIN PAR4 PROBLEM BY INHIBITING THE NATURAL ANTISMAL TRANSCRIPT OF THE PAR4 GENE |
| abstract | 1. A method of modulating the function and / or expression of a PAR4 polynucleotide in a biological system, comprising: contacting said system with at least one antisense oligonucleotide of 5 to 30 nucleotides in length, wherein said at least one oligonucleotide has at least 50% identity a sequence with a sequence that is a reverse complement of the natural antisense sequence for the PAR4 polynucleotide; resulting in modulation of the function and / or expression of the PAR4.2 polynucleotide. A method for modulating the function and / or expression of a PAR4 polynucleotide in a biological system according to claim 1, comprising: contacting said biological system with at least one antisense oligonucleotide of 5 to 30 nucleotides in length, wherein said at least one oligonucleotide has at least 50% sequence identity with a sequence that is the reverse complement of a polynucleotide containing 5 to 30 consecutive nucleotides within nucleotides 1-354 of the natural anti semantic transcript corresponding to SEQ ID NO: 2; resulting in modulation of the function and / or expression of the PAR4.3 polynucleotide. A method of modulating the function and / or expression of a PAR4 polynucleotide in a patient’s cells or tissues in vivo or in vitro, comprising: contacting said cells or tissues with at least one antisense oligonucleotide of 5 to 30 nucleotides in length, said oligonucleotide having at least 50% sequence identity with antisense oligonucleotide for polynucleotide PAR |
| priorityDate | 2010-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.